Literature DB >> 17652677

Peripheral line dead space: an unrecognised phenomenon?

Dave Geggie1, Deborah Moore.   

Abstract

OBJECTIVE: To determine if peripheral intravenous cannula dead space is taken into account when setting up intravenous infusions (in particular nitrate infusions) in the emergency department.
METHOD: A postal survey of UK emergency departments.
RESULTS: Of the 143 (58%) of UK departments who responded, only 15% reported priming the cannula before commencing the nitrate infusion.
CONCLUSIONS: Knowledge of peripheral intravenous cannula dead space in UK emergency departments is very poor and, as a result, there is probably significant widespread under treatment of patients in severe cardiogenic pulmonary oedema. Departments should amend their treatment guidelines to take account of peripheral cannula dead space.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652677      PMCID: PMC2660080          DOI: 10.1136/emj.2007.046250

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  1 in total

1.  Crisis management during anaesthesia: vascular access problems.

Authors:  R J Singleton; S B Kinnear; M Currie; S C Helps
Journal:  Qual Saf Health Care       Date:  2005-06
  1 in total
  3 in total

1.  Multiple Intravenous Infusions Phase 2b: Laboratory Study.

Authors:  Sonia Pinkney; Mark Fan; Katherine Chan; Christine Koczmara; Christopher Colvin; Farzan Sasangohar; Caterina Masino; Anthony Easty; Patricia Trbovich
Journal:  Ont Health Technol Assess Ser       Date:  2014-05-01

Review 2.  Essential elements of the native glucoregulatory system, which, if appreciated, may help improve the function of glucose controllers in the intensive care unit setting.

Authors:  Leon DeJournett
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

3.  A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.

Authors:  F M Buyle; J Decruyenaere; J De Waele; P M Tulkens; T Van Audenrode; P Depuydt; G Claeys; H Robays; D Vogelaers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-28       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.